CD8A and neoplasm: Additionally, the mRNA UNE-C1 treatment group exhibited an increase in migratory CD103+ and lymphoid-resident CD8+ DCs within the Tumor-draining lymph nodes (TdLN), both of which belong to the DC1 subset and are essential for priming CD8+ T cells (Figures 5D, E).